Recurrent DNMT3A Mutations In Patients with Myelodysplastic Syndrome

被引:0
|
作者
Walter, Matthew J. [1 ]
Shen, Dong [1 ]
Shao, Jin [1 ]
Ding, Li [1 ]
Grillot, Marcus [1 ]
McLellan, Michael [1 ]
Fulton, Robert [1 ]
Schmidt, Heather [1 ]
Kalicki-Veizer, Joelle [1 ]
O'Laughlin, Michelle [1 ]
Westervelt, Peter [1 ]
DiPersio, John F. [1 ]
Mardis, Elaine R. [1 ]
Wilson, Richard [1 ]
Ley, Timothy J. [1 ]
Graubert, Timothy [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Siteman Canc Ctr,Genome Ctr, St Louis, MO 63110 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:267 / 268
页数:2
相关论文
共 50 条
  • [31] DNMT3A MUTATIONS ARE NOT A RELIABLE MARKER OF MRD IN AML
    Alfonso, V.
    Iaccarino, L.
    Ottone, T.
    Maurillo, L.
    Buccisano, F.
    Mancini, M.
    Cicconi, L.
    Lavorgna, S.
    Venditti, A.
    Consalvo, M. Irno
    Angelini, D. F.
    Battistini, L.
    Del Principe, M. I.
    Voso, M. T.
    Lo-Coco, F.
    HAEMATOLOGICA, 2016, 101 : S47 - S48
  • [32] Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability
    Katrina Tatton-Brown
    Sheila Seal
    Elise Ruark
    Jenny Harmer
    Emma Ramsay
    Silvana del Vecchio Duarte
    Anna Zachariou
    Sandra Hanks
    Eleanor O'Brien
    Lise Aksglaede
    Diana Baralle
    Tabib Dabir
    Blanca Gener
    David Goudie
    Tessa Homfray
    Ajith Kumar
    Daniela T Pilz
    Angelo Selicorni
    I Karen Temple
    Lionel Van Maldergem
    Naomi Yachelevich
    Robert van Montfort
    Nazneen Rahman
    Nature Genetics, 2014, 46 : 385 - 388
  • [33] DNMT3A Gene: Distribution of the Mutations and their Stability during Treatment in Patients with AML
    Jeziskova, I.
    Musilova, M.
    Culen, M.
    Foltankova, V.
    Dvorakova, D.
    Mayer, J.
    Racil, Z.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 78 - 78
  • [34] DNMT3A Gene: Distribution of the Mutations and their Stability during Treatment in Patients with AML
    Jeziskova, I.
    Musilova, M.
    Culen, M.
    Foltankova, V.
    Dvorakova, D.
    Mayer, J.
    Racil, Z.
    ANNALS OF HEMATOLOGY, 2015, 94 : S78 - S78
  • [35] DNMT3A mutations in AML: A new prognostic factor?
    Schwarz, Jiri
    Markova, Jana
    LEUKEMIA RESEARCH, 2013, 37 (11) : 1432 - 1433
  • [36] Landmark Analyses of DNMT3A Mutations in Hematological Malignancies
    Grossmann, Vera
    Kohlmann, Alexander
    Haferlach, Claudia
    Alpermann, Tamara
    Wild, Melanie
    Weissmann, Sandra
    Eder, Christiane
    Dicker, Frank
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Torsten
    BLOOD, 2011, 118 (21) : 186 - 187
  • [37] Skeletal abnormalities in mice with Dnmt3a missense mutations
    Bell-Hensley, Austin
    Beard, Diana C.
    Feeney, Kathryn
    Zheng, Hongjun
    Jiang, Yunhao
    Zhang, Xiyun
    Liu, Jin
    Gabel, Harrison
    McAlinden, Audrey
    BONE, 2024, 183
  • [38] DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
    Quanyi Lu
    Yamei Chen
    Hang Wang
    Zhipeng Li
    Cancer Cell International, 13
  • [39] Abnormal expressions of plasma DNMT3A in elderly patients with recurrent atrial fibrillation
    Zeng, Huan
    Liu, Xinzong
    Li, Ying
    Zhou, Chang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (03): : 1468 - 1477
  • [40] DNMT3A Mutations Are not a Reliable Marker of MRD in AML
    Alfonso, V.
    Iaccarino, L.
    Ottone, T.
    Maurillo, L.
    Buccisano, F.
    Mancini, M.
    Cicconi, L.
    Lavorgna, S.
    Venditti, A.
    Consalvo, M. Irno
    Angelini, D. F.
    Battistini, L.
    Del Principe, M. I.
    Voso, M. T.
    Lo-Coco, F.
    ANNALS OF HEMATOLOGY, 2017, 96 : S62 - S63